Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine.
Two patients presented with very different signs of central anticholinergic syndrome following general anaesthesia for which they had received premedication with hyoscine. Both responded dramatically to 1 mg of intravenous (i.v.) physostigmine, which produced a rapid return to a normal level of consciousness. The aetiology of central anticholinergic syndrome is multi-factorial, but the diagnosis should be considered in all patients who demonstrate abnormal post-anaesthetic awakening. It is recommended that 1 mg of intravenous physostigmine is a safe and effective treatment for central anticholinergic syndrome, and that a supply of this important drug must be kept readily available in the recovery area of the operating theatre department.
Martin
B
B
Department of Anaesthesia, St Bartholomew's Hospital, London, UK.
Howell
P R
PR
D000328:Adult; D000758:Anesthesia / Q000009:adverse effects*; D001784:Blood Gas Analysis; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007431:Intraoperative Complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects*; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*; D012601:Scopolamine / Q000009:adverse effects*
D018678:Cholinergic Agents; D018727:Muscarinic Antagonists; D010830:Physostigmine; D012601:Scopolamine